{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:48:46Z","timestamp":1789951726975,"version":"4.0.1"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1772,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.exphem.2017.04.010","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T14:31:37Z","timestamp":1493908297000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["CBP\/Catenin antagonists: Targeting LSCs\u2019 Achilles heel"],"prefix":"10.1016","volume":"52","author":[{"given":"Yong-Mi","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ji","family":"Gang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2017.04.010_bib1","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1073\/pnas.0400629101","article-title":"Self-renewal capacity is a widespread property of various types of neural crest precursor cells","volume":"101","author":"Trentin","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2017.04.010_bib2","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1242\/dev.091777","article-title":"Stem cell metabolism in tissue development and aging","volume":"140","author":"Shyh-Chang","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.exphem.2017.04.010_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0301-472X(99)00157-5","article-title":"Genetic regulation of primitive hematopoietic stem cell senescence","volume":"28","author":"Chen","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2017.04.010_bib4","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nature05567","article-title":"Cancer biology: Gone but not forgotten","volume":"445","author":"Sharpless","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.04.010_bib5","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1182\/blood-2008-08-078220","article-title":"The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases","volume":"112","author":"Weissman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2017.04.010_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gde.2005.12.008","article-title":"Stem cells in the etiology and treatment of cancer","volume":"16","author":"Zhang","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.exphem.2017.04.010_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.04.010_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11899-012-0148-8","article-title":"Targeting chronic myeloid leukemia stem cells","volume":"8","author":"Kinstrie","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.exphem.2017.04.010_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2014.01.031","article-title":"Functional heterogeneity of genetically defined subclones in acute myeloid leukemia","volume":"25","author":"Klco","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.cell.2015.11.013","article-title":"Transcriptional heterogeneity and lineage commitment in myeloid progenitors","volume":"163","author":"Paul","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/leu.2016.364","article-title":"Preleukemia: One name, many meanings","volume":"31","author":"Koeffler","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.010_bib13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2013.100","article-title":"An evolutionary perspective on chronic myelomonocytic leukemia","volume":"27","author":"Itzykson","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.010_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12185-011-0793-z","article-title":"Maintenance of genomic integrity in hematopoietic stem cells","volume":"93","author":"Naka","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2017.04.010_bib15","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1002\/stem.2208","article-title":"Functional niche competition between normal hematopoietic stem and progenitor cells and myeloid leukemia cells","volume":"33","author":"Glait-Santar","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2017.04.010_bib16","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.1317072111","article-title":"The ecology in the hematopoietic stem cell niche determines the clinical outcome in chronic myeloid leukemia","volume":"111","author":"MacLean","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2017.04.010_bib17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00018-016-2306-y","article-title":"The hematopoietic stem-cell niche in health and leukemia","volume":"74","author":"Sanchez-Aguilera","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.exphem.2017.04.010_bib18","article-title":"The bone marrow microenvironment: Home of the leukemic blasts","author":"Shafat","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.exphem.2017.04.010_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/cas.12958","article-title":"To wake up cancer stem cells, or to let them sleep, that is the question","volume":"107","author":"Takeishi","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2017.04.010_bib20","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1158\/1078-0432.CCR-09-2933","article-title":"The difficulty of targeting cancer stem cell niches","volume":"16","author":"LaBarge","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2017.04.010_bib21","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-09-2823","article-title":"Targeting Notch to target cancer stem cells","volume":"16","author":"Pannuti","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"Database issue","key":"10.1016\/j.exphem.2017.04.010_bib22","first-page":"D377","article-title":"PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees","volume":"41","author":"Mi","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2017.04.010_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","article-title":"The complex world of WNT receptor signalling","volume":"13","author":"Niehrs","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2017.04.010_bib24","first-page":"cm1","article-title":"Wnt\/beta-catenin pathway","volume":"2005","author":"Moon","year":"2005","journal-title":"Sci STKE"},{"key":"10.1016\/j.exphem.2017.04.010_bib25","first-page":"1","article-title":"The role of the Wnt signaling pathway in cancer stem cells: Prospects for drug development","volume":"4","author":"Kim","year":"2014","journal-title":"Res Rep Biochem"},{"key":"10.1016\/j.exphem.2017.04.010_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ncb3349","article-title":"Orchestrating Wnt signalling for metabolic liver zonation","volume":"18","author":"Birchmeier","year":"2016","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2017.04.010_bib27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/cancers8090078","article-title":"Aberrant Wnt signaling in leukemia","volume":"8","author":"Staal","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.exphem.2017.04.010_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/156800911794328420","article-title":"The gamma catenin\/CBP complex maintains survivin transcription in beta-catenin deficient\/depleted cancer cells","volume":"11","author":"Kim","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.exphem.2017.04.010_bib29","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1038\/onc.2011.86","article-title":"beta-Catenin is required for Ron receptor-induced mammary tumorigenesis","volume":"30","author":"Wagh","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2017.04.010_bib30","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1158\/0008-5472.CAN-05-2057","article-title":"SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling","volume":"66","author":"Coluccia","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2017.04.010_bib31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.febslet.2006.01.034","article-title":"Bcr interferes with beta-catenin\u2013Tcf1 interaction","volume":"580","author":"Ress","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.exphem.2017.04.010_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1349-7006.2009.01430.x","article-title":"CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis","volume":"101","author":"Ishimoto","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2017.04.010_bib33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ncb2102","article-title":"O2 regulates stem cells through Wnt\/beta-catenin signalling","volume":"12","author":"Mazumdar","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2017.04.010_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/1874467207666140219121219","article-title":"Hypoxia selects for a quiescent, CML stem\/leukemia initiating-like population dependent on CBP\/catenin transcription","volume":"6","author":"Kida","year":"2013","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.exphem.2017.04.010_bib35","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.molcel.2012.11.022","article-title":"Glucose-induced beta-catenin acetylation enhances Wnt signaling in cancer","volume":"49","author":"Chocarro-Calvo","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2005.12.007","article-title":"Balancing cell adhesion and Wnt signaling, the key role of beta-catenin","volume":"16","author":"Brembeck","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.exphem.2017.04.010_bib37","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/gut.2010.233460","article-title":"Beta-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis","volume":"60","author":"van Veelen","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.exphem.2017.04.010_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm979","article-title":"Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor","volume":"10","author":"Sato","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2017.04.010_bib39","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1242\/dev.01218","article-title":"Beta-catenin signaling is required for neural differentiation of embryonic stem cells","volume":"131","author":"Otero","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.exphem.2017.04.010_bib40","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1083\/jcb.200209039","article-title":"Lineage-specific requirements of beta-catenin in neural crest development","volume":"159","author":"Hari","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.exphem.2017.04.010_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature01593","article-title":"A role for Wnt signalling in self-renewal of haematopoietic stem cells","volume":"423","author":"Reya","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.04.010_bib42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2007-07-099754","article-title":"Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis","volume":"111","author":"Koch","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.stem.2011.07.017","article-title":"Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion","volume":"9","author":"Luis","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","article-title":"Genetic and pharmacologic inhibition of beta-catenin targets imatinib-resistant leukemia stem cells in CML","volume":"10","author":"Heidel","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature12883","article-title":"Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts","volume":"506","author":"Kode","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.04.010_bib46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in\u00a0vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1182\/blood-2007-07-102558","article-title":"Long-term, multilineage hematopoiesis occurs in the combined absence of beta-catenin and gamma-catenin","volume":"111","author":"Jeannet","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrm.2015.3","article-title":"Beyond beta-catenin: Prospects for a larger catenin network in the nucleus","volume":"17","author":"McCrea","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2017.04.010_bib49","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.bbagen.2012.08.010","article-title":"On the role of Wnt\/beta-catenin signaling in stem cells","volume":"1830","author":"Kuhl","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.exphem.2017.04.010_bib50","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1038\/emboj.2012.126","article-title":"Drugging Wnt signalling in cancer","volume":"31","author":"Polakis","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2017.04.010_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2017.04.010_bib52","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/sj.bjc.6604401","article-title":"Tumour\u2013stroma interactions in colorectal cancer: Converging on beta-catenin activation and cancer stemness","volume":"98","author":"Le","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.exphem.2017.04.010_bib53","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-09-2943","article-title":"Targeting Wnt signaling: Can we safely eradicate cancer stem cells?","volume":"16","author":"Takahashi-Yanaga","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2017.04.010_bib54","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.exphem.2017.04.010_bib55","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1182\/blood-2003-09-3335","article-title":"Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"Beta-catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Hu","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.010_bib57","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.addr.2010.09.012","article-title":"The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators","volume":"62","author":"Teo","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.exphem.2017.04.010_bib58","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/sj.onc.1208433","article-title":"Differential roles for the coactivators CBP and p300 on TCF\/beta-catenin-mediated survivin gene expression","volume":"24","author":"Ma","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2017.04.010_bib59","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1093\/emboj\/cdg473","article-title":"Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5","volume":"22","author":"Roth","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2017.04.010_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10565-016-9318-0","article-title":"Kat3 coactivators in somatic stem cells and cancer stem cells: Biological roles, evolution, and pharmacologic manipulation","volume":"32","author":"Thomas","year":"2016","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.exphem.2017.04.010_bib61","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1101\/gad.14.3.272","article-title":"Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP","volume":"14","author":"Kung","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2017.04.010_bib62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng829","article-title":"Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice","volume":"30","author":"Yamauchi","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2017.04.010_bib63","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S1359-6446(05)03613-5","article-title":"Investigating Wnt signaling: A chemogenomic safari","volume":"10","author":"McMillan","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.exphem.2017.04.010_bib64","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.1073\/pnas.0404875101","article-title":"A small molecule inhibitor of beta-catenin\/CREB-binding protein transcription [corrected]","volume":"101","author":"Emami","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2017.04.010_bib65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5966\/sctm.2011-0033","article-title":"Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion","volume":"1","author":"Hasegawa","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.exphem.2017.04.010_bib66","doi-asserted-by":"crossref","first-page":"e33165","DOI":"10.1371\/journal.pone.0033165","article-title":"Human embryonic stem cells differentiated\u00a0to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model","volume":"7","author":"Banerjee","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2017.04.010_bib67","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1073\/pnas.0701331104","article-title":"Wnt\/beta-catenin\/CBP signaling maintains long-term murine embryonic stem cell pluripotency","volume":"104","author":"Miyabayashi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2017.04.010_bib68","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1038\/onc.2015.438","article-title":"CBP\/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells","volume":"35","author":"Zhao","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2017.04.010_bib69","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.stem.2008.06.019","article-title":"Wnt signaling promotes reprogramming of somatic cells to pluripotency","volume":"3","author":"Marson","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib70","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1874467208666150526155146","article-title":"Specific direct small molecule p300\/beta-catenin antagonists maintain stem cell potency","volume":"9","author":"Higuchi","year":"2016","journal-title":"Curr Mol Pharmacol"},{"issue":"1 Suppl 1","key":"10.1016\/j.exphem.2017.04.010_bib71","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.seminoncol.2007.12.002","article-title":"Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia","volume":"35","author":"Giles","year":"2008","journal-title":"Semin Oncol"},{"key":"10.1016\/j.exphem.2017.04.010_bib72","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.clml.2013.03.018","article-title":"Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: A clinical perspective and emerging treatment options","volume":"13","author":"Jabbour","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.exphem.2017.04.010_bib73","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12185-010-0615-8","article-title":"Molecular pathways to CML stem cells","volume":"91","author":"Rice","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2017.04.010_bib74","first-page":"531","article-title":"Chronic versus acute myelogenous leukemia: A question of self-renewal","volume":"6","author":"Jamieson","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib75","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ceb.2007.02.007","article-title":"Wnt\/beta-catenin signaling in cancer stemness and malignant behavior","volume":"19","author":"Fodde","year":"2007","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.exphem.2017.04.010_bib76","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1182\/blood-2012-11-466938","article-title":"Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells","volume":"121","author":"Bolton-Gillespie","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib77","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.leukres.2008.11.013","article-title":"sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia","volume":"33","author":"Pehlivan","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2017.04.010_bib78","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/leu.2016.231","article-title":"Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy","volume":"31","author":"Chen","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.010_bib79","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood-2016-09-670224","article-title":"Myeloid malignancies and the microenvironment","volume":"129","author":"Korn","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib80","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","article-title":"The chronic myeloid leukemia stem cell: Stemming the tide of persistence","volume":"129","author":"Holyoake","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib81","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2010.10.032","article-title":"Beta-catenin mediates the establishment and drug resistance of MLL leukemic stem cells","volume":"18","author":"Yeung","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib82","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJMoa040258","article-title":"Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML","volume":"351","author":"Jamieson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2017.04.010_bib83","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2141.2007.06667.x","article-title":"Activation of Wnt\/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia","volume":"138","author":"Khan","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2017.04.010_bib84","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1038\/sj.onc.1208568","article-title":"Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis","volume":"24","author":"Mazieres","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2017.04.010_bib85","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1182\/blood-2011-04-351239","article-title":"Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia","volume":"118","author":"Park","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib86","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/leu.2011.249","article-title":"Targeting survivin and p53 in pediatric acute lymphoblastic leukemia","volume":"26","author":"Tyner","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.010_bib87","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/leu.2011.199","article-title":"Endogenous knockdown of survivin improves chemotherapeutic response in ALL models","volume":"26","author":"Morrison","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.010_bib88","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.leu.2404255","article-title":"Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia","volume":"20","author":"Weerkamp","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2017.04.010_bib89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3747\/co.23.2806","article-title":"Targeting leukemia stem cells: Which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia?","volume":"23","author":"Belmonte","year":"2016","journal-title":"Curr Oncol"},{"key":"10.1016\/j.exphem.2017.04.010_bib90","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1182\/blood-2006-11-059071","article-title":"Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation","volume":"109","author":"Guo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib91","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature06933","article-title":"Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation","volume":"453","author":"Guo","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.04.010_bib92","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2014-10-609370","article-title":"Leukemia stem cells in T-ALL require active Hif1alpha and Wnt signaling","volume":"125","author":"Giambra","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib93","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1038\/bcj.2014.12","article-title":"Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia","volume":"4","author":"Ng","year":"2014","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.exphem.2017.04.010_bib94","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt.1517","article-title":"Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells","volume":"27","author":"Foudi","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2017.04.010_bib95","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.celrep.2014.07.019","article-title":"Quantification of crypt and stem cell evolution in the normal and neoplastic human colon","volume":"8","author":"Baker","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2017.04.010_bib96","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/255197a0","article-title":"Mutation selection and the natural history of cancer","volume":"255","author":"Cairns","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.04.010_bib97","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.stem.2010.09.015","article-title":"mTOR activation induces tumor suppressors that inhibit leukemogenesis and deplete hematopoietic stem cells after Pten deletion","volume":"7","author":"Lee","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib98","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2009.06.048","article-title":"The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells","volume":"138","author":"Cicalese","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib99","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.stemcr.2014.05.016","article-title":"Genetic activation of Hedgehog signaling unbalances the rate of neural stem cell renewal by increasing symmetric divisions","volume":"3","author":"Ferent","year":"2014","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.exphem.2017.04.010_bib100","doi-asserted-by":"crossref","first-page":"12171","DOI":"10.1073\/pnas.0504600102","article-title":"Specific inhibition of CBP\/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation","volume":"102","author":"Teo","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2017.04.010_bib101","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/onc.2013.169","article-title":"Small-molecule inhibition of CBP\/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia","volume":"33","author":"Gang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2017.04.010_bib102","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2017.04.010_bib103","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2017.04.010_bib104","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2017.04.010_bib105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12015-014-9515-2","article-title":"Wnt\/catenin signaling in adult stem cell physiology and disease","volume":"10","author":"Ring","year":"2014","journal-title":"Stem Cell Rev"},{"issue":"Suppl","key":"10.1016\/j.exphem.2017.04.010_bib106","article-title":"A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors","volume":"31","author":"El-Khoueiry","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2017.04.010_bib107","doi-asserted-by":"crossref","first-page":"248","DOI":"10.20892\/j.issn.2095-3941.2016.0023","article-title":"Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang","volume":"13","author":"Zhou","year":"2016","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.exphem.2017.04.010_bib108","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/emboj.2013.127","article-title":"Wnt\/beta-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours","volume":"32","author":"Wend","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2017.04.010_bib109","doi-asserted-by":"crossref","first-page":"9979","DOI":"10.1038\/srep09979","article-title":"Therapeutic targeting of CBP\/beta-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin","volume":"5","author":"Chan","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2017.04.010_bib110","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.exphem.2013.09.007","article-title":"Resilient and resourceful: Genome maintenance strategies in hematopoietic stem cells","volume":"41","author":"Bakker","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2017.04.010_bib111","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrg2269","article-title":"Deconstructing stem cell self-renewal: Genetic insights into cell-cycle regulation","volume":"9","author":"Orford","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2017.04.010_bib112","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.tcb.2014.04.001","article-title":"Surviving change: The metabolic journey of hematopoietic stem cells","volume":"24","author":"Kohli","year":"2014","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.exphem.2017.04.010_bib113","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2011.07.003","article-title":"Anaerobicizing into pluripotency","volume":"14","author":"Panopoulos","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.exphem.2017.04.010_bib114","doi-asserted-by":"crossref","first-page":"39","DOI":"10.15283\/ijsc.2012.5.1.39","article-title":"Evolution of energy metabolism, stem cells and cancer stem cells: How the Warburg and Barker hypotheses might be linked","volume":"5","author":"Trosko","year":"2012","journal-title":"Int J Stem Cells"},{"key":"10.1016\/j.exphem.2017.04.010_bib115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0092-8674(94)90127-9","article-title":"E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators","volume":"77","author":"Arany","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2017.04.010_bib116","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1101\/gad.8.8.869","article-title":"Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor","volume":"8","author":"Eckner","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2017.04.010_bib117","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mc.20280","article-title":"Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines","volume":"46","author":"Dillard","year":"2007","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.exphem.2017.04.010_bib118","first-page":"4197","article-title":"Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid","volume":"61","author":"Szeto","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2017.04.010_bib119","doi-asserted-by":"crossref","first-page":"61563","DOI":"10.1155\/2007\/61563","article-title":"Nuclear receptors in regulation of mouse ES cell pluripotency and differentiation","volume":"2007","author":"Mullen","year":"2007","journal-title":"PPAR Res"},{"key":"10.1016\/j.exphem.2017.04.010_bib120","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.2882","article-title":"A PML\u2013PPAR\u2013delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance","volume":"18","author":"Ito","year":"2012","journal-title":"Nat Med"},{"issue":"Pt 20","key":"10.1016\/j.exphem.2017.04.010_bib121","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1242\/jcs.051011","article-title":"mTOR signaling at a glance","volume":"122","author":"Laplante","year":"2009","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2017.04.010_bib122","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1074\/jbc.M111.300194","article-title":"Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells","volume":"287","author":"Ianculescu","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2017.04.010_bib123","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1073\/pnas.93.26.15092","article-title":"Two contact regions between Stat1 and CBP\/p300 in interferon gamma signaling","volume":"93","author":"Zhang","year":"1996","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1730142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1730142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T01:28:06Z","timestamp":1654910886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X1730142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":123,"alternative-id":["S0301472X1730142X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2017.04.010","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CBP\/Catenin antagonists: Targeting LSCs\u2019 Achilles heel","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2017.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}